Many of those initial approaches were aiming to identify existing compounds to prevent viral infection by either targeting mechanisms involving the viral receptor ACE2 (angiotensin converting enzyme 2), the TMPRSS2 transmembrane protease serine 2, or clathrin-mediated endocytosis [14–16]. Here, ACE2 is linked to viral infectious disease.